Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3137631 A
Publication typeGrant
Publication dateJun 16, 1964
Filing dateDec 1, 1959
Priority dateDec 1, 1959
Publication numberUS 3137631 A, US 3137631A, US-A-3137631, US3137631 A, US3137631A
InventorsSaul Soloway
Original AssigneeFaberge Inc
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Encapsulation in natural products
US 3137631 A
Images(4)
Previous page
Next page
Description  (OCR text may contain errors)

3,137,631 EN CAPSULATION 1N NATURAL PRODUCTS Saul Soloway, New Rochelle, N.Y., assignor, by mesne assignments, to Faberge, Inc., Ridgefield, NJL, a corporation of Delaware No Drawing. Filed Dec. 1, 1959, Ser. No. 856,379 11 Claims. (Cl. 167-83) This invention relates to encapsulating water insoluble organic liquids and the resulting products.

Those liquids, compounds or mixtures, which have appreciable vapor pressures or which are subject to chemical change by reaction with some atmospheric constituent, may be protected from volatilization or reaction with the environment by enclosure in inert capsules. Solids, having similar properties, may be dissolved in appropriate liquids and then encapsulated as solutions. Some of the volatile essential oils of commerce which could be encapsulated to advantage for applications to be discussed later are: oils of lemon, orange, anise, pine, almond, thyme, rose, jasmine and citronella. In fact one might include all the oils used in the perfume, flavor, food and allied industries. Specific types of compounds such as aldehydes, olefins, acetylenes, mercaptans, amines, ethers and phenols are readily protected against autoxidation by encapsulation. Protection of oxygen sensitive compounds without the use of an anti oxidant is particularly desirable for the preservation of animal fats, vegetable oils and vitamins such as A, E, and C. The general use of anti oxidants in these instances is viewed as that of a necessary contaminant.

It is often desirable to envelop substances, which may or may not be stable, in capsules which are frangible. Such capsules may be integrated into a fabric, woven or non-woven, so that the application of pressure will release the material. This concept constitutes a novel Way of dispensing perfume and certain types of medication. The encapsulation of such voltile compounds as menthol, camphor, pine oil, oil of eucalyptus, etc. offers a most convenient mode of dispensing alleviants for respiratory disease.

The separate encapsulation of two or more potential reactants offers many possibilities. Carbonless Carbon Paper can be made by coating the under side of one sheet of paper with capsules containing a potential color forming reactant. The top side of a second sheet is impregnated with capsules containing the developing reagent. The application of pressure to the pair of sheets in contact causes both types of capsules to rupture, thereby releasing the contents with consequent color development.

For the reasons given above, many attempts have been made to encapsulate organic substances which are in soluble in Water and are liquid at temperatures at which water is liquid. (Such substances are hereinafter called water insoluble organic liquids.) For example, efforts have been made to encapsulate such substances in gels or encompass them in waxes. Such efforts have not been adequately successful because of rapid leakage through the gel and structural weakness of the wax. Waxes are also readily dissolved by most organic oils and hence are only limited to use for encapsulating polar liquids.

' It is a principal object of this invention to overcome, or at least abate the drawbacks heretofore associated with encapsulating water insoluble organic liquids. It is a special object of this invention to provide an encapsulating process which can be carried out at the mild temperature at which water is liquid. It is a special object of this invention to encapsulate volatile substances such as perfume coils or substances which favorably affect respiration. Other objects and features of the invention A United States Patent will become apparent from the more detailed description of the invention which follows.

In my copending application Serial No. 846,535, filed October 15, 1959, now abandoned, it was disclosed that the aforesaid objectives can be obtained by encapsulating water insoluble liquids, such as mentioned above, in solid shells of cross-linked synthetic resins. These encapsulating cross-linked synthetic resin shells, as is known, are water insoluble and are insoluble in usual organic solvents. In order to encapsulate the water insoluble organic liquids in the synthetic crosslinked resin shells, the water insoluble organic liquid was dispersed in an aqueous solution of compounds capable of forming cross-linked synthetic resins by the application of heat or catalyst or both and then the resinforming compounds were polymerized in the presence of the dispersed Water insoluble liquids to thereby encapsulate them. Urea-aldehyde prepolymers are disclosed as being especially suitable for use in such a process but Water soluble resins forming compounds capable of forming melamine, epoxy, thiourea, polyamide, dicyanodiamidealdehyde resins are likewise disclosed as being suitable.

In special embodiments of that invention, the water insoluble organic liquids were disclosed as being encapsulated in a plurality of concentric shells made of the same or different resin-forming compounds or in a composite shell composed of a plurality of resin-forming compounds. In a particular embodiment of that invention, it was disclosed that the water insoluble organic liquids could be encapsulated in a water insoluble composite shell derived conjointly from water soluble heat denaturable proteins and water soluble compounds which form cross-linked synthetic resins.

In accordance with this invention, the objectives set out above, and other valuable objectives, are obtained by encapsulating water insoluble organic liquids in water insoluble shells derived from water soluble heat denaturable proteins. In order to encapsulate the water insoluble organic liquids, they are dispersed in an aqueous solution of the water soluble proteins and the proteins are then denatured in the presence of the dispersed particles of water insoluble organic liquids to thereby encapsulate the particles in a water insoluble solid protein shell. In an important method of practicing the invention, the proteins are denatured by the application of heat but they can be denatured by use of other kinds of energy as by use of ultraviolet light or ultrasonic sound or by chemicals as by acid or alkali denaturing. Although valuable substances in capsule form may be obtained by encapsulating the Water insoluble organic liquids in shells derived from water soluble heat denaturable proteins alone, known cross-linking agents for proteins such as formaldehyde, glyoxal and the like may be used to react with the proteins during the formation of the shell, or after the shell is formed, to impart increased stability to the capsule. By following the process hereof water insoluble organic liquids are encapsulated in a substantially impermeable shell of a denatured denaturable protein.

While no theory is necessary to an understanding of this invention, it is felt that the dissolved water soluble proteins normally have some aflinity for the diluted dispersion of globules of water insoluble organic'liquids and, therefore, tend to concentrate at the interface between the globules and the continuous aqueous phase. In this way, the proteins form a coating around the globules and, when denatured, form a solid water insoluble capsule therearound.

If desired, known emulsifying agents, which are usually of an oily or fatty nature, may be used to facilitate the formation of an aqueous dispersion.

Egg albumin has proven especially valuable as a source of heat denaturable protein for, among other things,

the egg albumin is a good emulsifying agent and the ta water bath. At 65 C.

water insoluble organic liquid can be easily dispersed in the aqueous body'in the presence of egg albumin by mechanical agitation with a conventional high speed mixer. Other water soluble and heat denaturable proteins I suitable for use in the process of this invention include blood, other albumins, blood plasma, globulin, myosin,

glutelin, excelsin, edestin, arachin, casein and like water soluble proteins and their mixtures which become denatured by heating. I t I In the encapsulating process disclosed above, the water soluble proteins maybe effectively and economically denatured by the application of heat tothereby form a I water insoluble solid shell around the water insoluble liquid. On the other hand, other forms of energy or chemical means may be'used to denature the proteins and render them water insoluble as by the use of ultraviolet light, ultrasonic sound or by the use of chemicals such as acid or alkali denaturants.

Thus, broadly considered, the present invention relates to a process for encapsulating, or coating, particles 'of water insoluble organic liquids'withdenatured and water a I insolubilized proteins and to. the resulting encapsulated I product. In accordance with a more limited aspect of the invention, the invention'relates to a process involving dispersing particles of a water insoluble organic compound in anaqueous solution of a water soluble heat denaturable protein-thereby applying to and absorbing on the surfaces of the dispersed particles the heat denaturable protein and denaturing the protein on the surfaces of the' particles until it'becornes substantially water insoluble, i.e., cross-linked.

If desired, the dispersion of the water insoluble organic liquid in the aqueous media may be facilitated by using I a water soluble thickening agent, or an agent imparting colloidality to the media. Compounds found very useful as thickening agents include methyl cellulose, hy-

droxyethyl cellulose and sodium carboxymethyl cellulose V and similar compounds known to improve the sus end, ing capacity of aqueous media. Although these colloids are water soluble, they also have some affinity for the Water insoluble organic liquid. ,Thus, thesefcolloids fa cilitate the formation ofv an aqueous dispersion of the organic liquid and have a tendency to concentrate at the interface between the dispersed Water insoluble organic liquid and the continuous aqueous phase. In this way,

the encapsulation is aided.

In many instances sequential coating of the dispersed water insoluble organic liquid particles gives an importantly improved encapsulated material enclosed in concentric shells. In this way, two or more concentric shells composed of water insolubilized proteins may be formed around the water insoluble organic liquid as disclosed herein or concentric shells respectively composed of water insolubilized proteins and cross-linked resins may serve as fillers for any imperfectly formed capsules containing micro cracks. I I

The meaning and significance of the invention will become even more apparent from the following illustrative examples. a

EXAMPLE I I Methyl'Benzoate Encapsulated in Egg'Albumin I Twenty-seven (27) grams of'methyl 'benzoate were added to a solution of ,ZO grams of egg'albumin in' 230 ml. of water at room temperature. The mixture was stirred at approximately 300 r.p.m. and heated on I asuspension in benzene.

ture waspoured into 800 ml. of tap water. Two solid phases formed. One was lighter and the otherhe'avier than the aqueous medium. The less dense solid was washed extensively with methanol. The heavier solid was washed with'water several times by decantation y Both washed solids were dried at 50C. with air'cir vculating through the oven; The odorless mass liberated the odor of methyl benzoate on rubbingthe solid par- 'ti cles against'one another. I

' I EXAMPLE 2 Pinene Encapsulated in Egg Albumin One hundred lOO) grams of pinene were emulsified I I in a solution of'45 grams of egg albumin dissolved in A 900 grams of water. The resulting suspension washeated on a water bath at a rateof 2 to 3 degrees O per minute;

The main batch "of solids was split into' t wo parts One was treated with '30 grams of 37%aqueous form-" aldehyde and the other with 40 grams of 30% glyoxal. Both batches were heated to C. for 15 minutes.

The separation and @drying'steps Were thesame asde scribed in the first"preparation; The resulting dried glyoxal treated material was quite hard and difficultto break by crushing with the fingers. yielded odor on the applicationof frictional forces. Q

EXAMPLIEIISI' Encapsulation of Born'yl Acetate in Bornyl acetate wassuccessfully encapsulated inegg I albumin in weight ratiosfof 1:1 and 2:1 and thereafter treated with formaldehyde by following the procedure I as disclosed in Example 2. An experiment using a3 to 1 ratio had a tendency to oil out. I I s v In these preparations the intial oil dispersion was passed through a colloid mill before theheating step. The final preparationconsisted'of particles of about 1 cm. in diameter. These were broken up in an osterizer as The separated particles were odor free on drying, but

ticle friction. a

- EXAMPLE 4 readily released the odor of bornyl acetate on inter par I V Encapsulation of:-'B 0rnyl Acetate. in Albumin and "Urea- I Formaldehyde Polymer Forty-five; (45) grams of bornyl acetatewere emulsified in a solution of 45 grams of egg albumin dissolved in 900 grams of water. The resulting dispersion was passed through a colloidal mill and the suspension was then heated on a water bath at a rate of 2 to'3 degrees C .'PI' minute. When the temperature reached C., it was held:

[phosphates were dissolved in 25 "grams of an oily-mass I consisting of a perfume oil'prepared from2 0% of each there for ten minutes. After the coagulation was completed, 10'grams of urea, 25. ml. of 35% formaldehyde,

and 1 mol of concentrated hydrochloric acid were'added I in successionand the heating was continued on the water bath until solid urea-formaldehyde resin wasno longer formed. The encapsulated solids were separated in the same .manner as in the preceding examples.

' EXAMPLE .5

Encapsulation of a Mixture of Essential Oils l Formaldehyde and Albumin Two (2) grams. of 'a mixture of mono: and' 'dilauryl Ureaof the following natural oils and synthetic compounds} B-phenyl ethylalcohol, 'geraniol, linalool, altarof 'Rose coagulation beganto set in. r After the temperature reached C;, thereaction mix I When the temperature reached 75 C., it was held there for ten minutes.

A small portion of theformed solids Wcresep'arated by decantation and washed with water and, acetone. This, prod'uct'yielded no pinene odor on crushing.

Both preparations I j 8 and oil of Neroli. This solution was added to a solution of 20 grams of urea in 300 ml. of water, followed by an addition of 50 ml. of 37% formaldehyde. While the above dispersion was being stirred, a solution of 10 grams of alubumin in 100 ml. of water was added dropwise over a period of 2 minutes. The albumin caused the oil to become more finely dispersed and seemed to coagulate around the droplets at room temperature. The preparation was heated in the manner as described in the preceding examples, filtered, Washed with water and isopropanol and dried. Stable capsules of the perfume oil were obtained.

EXAMPLE 6 Encapsulation a Mixture of Essential Oils in Urea- F ormaldelzyde, Albumin and Barium Sulfate Fifty (50) ml. of water was used to dissolve grams of urea, 12.5 grams of 37% aqueous formaldehyde, and 2.5 grams of sodium sulfate. Ten grams of the perfume oil of Example 5 and 1 gram of a mixture of mono and dilauryl phosphates were stirred into the aqueous solution while stirring with a stirrer rotating at 200-300 r.p.m. Then 5 grams of egg albumin in 25 ml. of water was added, and the stirring at 200-300 r.p.m. continued for a half hour. After reaction period induced by heating the reaction mass, the urea formaldehyde resin and the denatured egg albumin were formed into a shell around the oil. A dilute barium chloride solution was then added to form a final coat of barium sulfate with the aqueous sulfate ion present. A very stable encapsulated perfume oil was obtained encased in the cross-linked resins and the coating of barium sulfate.

Colloidal silica or powdered titanium dioxide could be added, at this point in the procedure, in lieu of barium chloride.

EXAMPLE 7 Encapsulation of Normally Solid Volatile Compounds A liquid mixture of 30 grams'of menthol, 10 grams of camphor, and 10 grams of bornyl acetate was stirred and dispersed in 50 grams of 10% methyl cellulose c.p.s.) in water. Fifty grams of an aqueous acidic colloidal solution containing 10% of an urea-formaldehyde prepolymer was added to this dispersion. After stirring, at room temperature, for a half hour, 50 grams of a 10% aqueous egg albumin solution was added and the stirring continued for an equal period. The resulting suspension of capsules may be washed free of mother liquid or used as such for spray-drying, brush or blade application to the surface of paper or other nonwoven or woven fibrous materials.

This preparation can be made odor free by air-drying the filtered, or centrifuged, capsules overnight in an oven kept at 50 to 60 C.

Also, where it is desired to obtain an intimate admixture of the encapsulated material and the carrier, such as in the production of paper for producing a paper handkerchief it is possible to introduce the capsules into the carrier during its manufacture such as by mixing together an aqueous paper pulp and the aqueous suspension of capsules during the processing of the pulp to paper.

A very satisfactory product for the alleviation of colds has been obtained by incorporating the capsules of this example in non-woven paper tissue. Other types of nonwoven fibrous tissue may be used in the same way.

While the preceding examples have related to encapsulating volatile water insoluble organic liquids, especially perfume oils and aromatics, it will be understood that other types of water insoluble liquids, mentioned herein, may be encapsulated by following the same procedure. Also, water soluble heat hardenable proteins may be dissolved in the aqueous medium in place of the egg albumin in equivalent proportions, to encapsulate the water insoluble organic liquids in the other types of denatured proteins derived from the other proteins disclosed above. Likewise, other resins typified by those disclosed hereinbefore, may be substituted for the urea-formaldehyde resins of the examples to modify the denatured protein capsules.

It is apparent from the foregoing discussion that encapsulation and encapsulate has reference to the formation of solid shells or capsules around the dispersed globules of water insoluble organic liquids. As pointed out in the body of the specification and in the specific examples, a dilute suspension of the organic liquid is first formed in an aqueous solution of the heat denaturable protein. These water soluble heat denaturable proteins can concentrate at the oil-water interface where they are insolubilized and formed into a denatured protein shell encapsulating the water insoluble oil by the action of heat or by other methods set out above.

It will be understood the foregoing general description as complemented by the specific examples has served to illustrate the invention and its principles. However, many modifications and variations in the details of the disclosure will occur to those skilled in the art to which the invention appertains and still remain within the principles of the invention and its scope. For instance, the illustrative embodiments of the invention have been concerned primarily with encapsulating water insoluble organic compounds which are liquid at temperatures at which water is liquid and with encapsulating such compounds containing dissolved, or otherwise dispersed therein, additional ingredients which are readily dispersed in the water insoluble organic compounds. It will be apparent, however, that the principles of the invention can be applied to encapsulating ingredients which are more difiicult to disperse in the water insoluble organic liquids. Broadly considered, the principles of this invention can be applied to the encapsulation of any ingredient which has a greater affinity for the water insoluble organic liquid than it has for Water. For example, when the water insoluble organic compound is an oil any ingredient may be kept in dispersion in the dispersed oil phase which is more lipophilic than hydrophilic. Predominantly lipophilic emulsifiers could be used to assist in the dispersion of the substances in the oil phase. The same principle may be used to encapsulate solids which are insoluble both in the oil phase and in the water. For example, the absorption, or coating, of a substance onto the solid particles being dispersed in the oil phase which has an amnity for oil and then dispersing the solid in the oil before it is, in turn, dispersed in the water for encapsulation. This latter principle can be used even to disperse and then encapsulate water soluble solids.

Thus, it will be seen the invention is capable of many modifications as to details and still remain within the scope of the invention as defined in the claims.

What is claimed is:

1. A liquid phase process for encapsulating a water insoluble organic liquid, which comprises dispersing finely divided particles of said liquid and a solution of a water soluble heat denaturable albumin in a body of water, denaturing said albumin by the application of heat until it forms a substantially water insoluble denatured protein coating around said particles while said particles are dispersed in said body of Water thereby encapsulating the particles in a solid shell and separating the encapsulated particles from the body of water.

2. A liquid phase process for encapsulating a water insoluble organic liquid, which comprises dispersing finely divided particles of said liquid and a solution of egg albumin in a body of water, heat denaturing said albumin until it forms a substantially water insoluble denatured egg albumin coating around said particles while said particles are dispersed in said body of water thereby encapsulating the particles in a solid shell and separating the encapsulated particles from the body of water.

'3. A liquid phase process for encapsulating a water insoluble organic liquid, which comprises dispersing finely divided particles of said liquid and a solution of a plurality ofwater soluble cross-linking resin-forming compounds in a' body ofwater, at least one of said resin-forming compounds being a heat denaturable albumin, denaturing said albumin by the application of heat and polymerizing any remaining resin-forming compounds until they deposit solution of a water soluble heat denaturable albumin in v a body of Water, applying heat to said body of water untilsaid albumin deposits a substantially water insoluble heat denatured albumin coating around said particles while said particles are dispersed in said body of Water thereby encapsulating particles in' a solid shell and separating the encapsulated particles from the body Of'WZlIGI". 5. A plurality of small discrete particles of a Water insoluble organic liquid encapsulated in a Water insoluble and substantially impermeable solid shell of a heat denatured albumin. 6. Finely divided particles of a water insoluble aromatic liquid encapsulated in a solid shell of a heat denatured albumin.

7. Finely divided particles of a liquid odoriferous substance encapsulated in a solid shell of a heat denatured egg albumin. g i V V,

8. Finely divided particlesof a perfume oil encapsulated in a solid shell of'a heat denatured egg albumin.

9.' A fibrous tissue having incorporated therein finely divided particles of a Water insoluble but Volatile liquid encapsulated in a heat denatured alb umin shell derived from, a Water soluble albumin.

10'. A plurality of small'discrete, particles ofa water insoluble organic liquid encapsulated in a water insoluble and substantially impermeable composite solid shell coma prising a heat denatured" albumin, "and across-linked imino synthetic resin.

7 11. l A paperltissue having incorporated therein a Water. insoluble but volatile decongestant encapsulatedin. a solid shell of aheat denatured water soluble albumin.

References Cited the file of this patent I IE sT riss PATENTS 2,491,475 Bogin Dec. 20, 1949 2,656,298 Loewe Oct. 20, 1953 2,797,201 Ve'atch et a1. June 25; 1957- 2,80Q,457 Green July 23; 1957 2,800,458 Green July 23,1957 2,870,062 Stanley, et a1. Jan. 20,- 1960 a 2,969,330 Brynko -i Ian, 24, 1961" Katchen et a1. June 2 6, 1962

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2491475 *Mar 25, 1946Dec 20, 1949Parke Davis & CoEnteric capsule
US2656298 *Nov 10, 1948Oct 20, 1953Jacques Loewe Res FoundationTherapeutic product
US2797201 *Oct 2, 1953Jun 25, 1957Standard Oil CoProcess of producing hollow particles and resulting product
US2800457 *Jun 30, 1953Jul 23, 1957Ncr CoOil-containing microscopic capsules and method of making them
US2800458 *Jun 30, 1953Jul 23, 1957Ncr CoOil-containing microscopic capsules and method of making them
US2870062 *Apr 27, 1956Jan 20, 1959Scherer Corp R PGelatin composition for capsules
US2969330 *Jun 4, 1958Jan 24, 1961Ncr CoOil containing capsules and method of making them
US3041289 *Jan 2, 1959Jun 26, 1962Ncr CoMethod of making walled clusters of capsules
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3257267 *May 19, 1965Jun 21, 1966Hay Harold RRetarding liberation of an additament in forming a fibrous web by embedding the additament in a gel matrix prior to addition to the fibers
US3293114 *Apr 3, 1964Dec 20, 1966Dow Chemical CoMethod of forming paper containing gaseous filled spheres of thermoplastic resins and paper thereof
US3384536 *Mar 24, 1965May 21, 1968Ncr CoProcess for forming fibrous sheets containing limited penetration of additaments within the sheet and sheets thereof
US3406119 *Mar 5, 1965Oct 15, 1968Keuffel & Esser CoEncapsulation
US3490454 *Oct 21, 1966Jan 20, 1970United Merchants & MfgCatamenial products having a coating of rupturable microcapsules containing medicants
US3515070 *May 15, 1968Jun 2, 1970Us ArmyChemiluminescent peraminoethylene positioned within a brittle capsule
US3516846 *Nov 18, 1969Jun 23, 1970Minnesota Mining & MfgMicrocapsule-containing paper
US3516941 *Jul 25, 1966Jun 23, 1970Minnesota Mining & MfgMicrocapsules and process of making
US3521637 *Nov 28, 1967Jul 28, 1970Haskett Barry FTampon or similar sanitary napkin containing vitamin a
US3623659 *Dec 29, 1969Nov 30, 1971Ncr CoArticles of manufacture containing encapsulated, vaporizable core material
US3663685 *Apr 1, 1968May 16, 1972Minnesota Mining & MfgBiodegradable radioactive particles
US3669899 *Apr 29, 1969Jun 13, 1972Us Plywood Champ Papers IncMicrocapsular opacifier system
US3720579 *Mar 16, 1971Mar 13, 1973Champion Int CorpFibrous substrates with microcapsular opacifiers
US3816169 *Apr 20, 1972Jun 11, 1974Champion Int CorpFibrous and non-fibrous substrates coated with microcapsular pacifier system and the production of such coated substrates
US3886084 *Aug 23, 1971May 27, 1975Champion Int CorpMicroencapsulation system
US3911099 *Jan 23, 1974Oct 7, 1975Defoney Brenman Mayes & BaronLong-acting articles for oral delivery and process
US3937668 *Nov 6, 1972Feb 10, 1976Ilse ZolleCarriers for drugs, insecticides, dyes, albumin
US3957964 *Jun 3, 1975May 18, 1976Colgate-Palmolive CompanyDentifrice containing encapsulated flavoring
US3978204 *Dec 12, 1974Aug 31, 1976L'orealCosmetic composition containing microencapsulated solvents for nail enamel
US4001480 *Aug 16, 1974Jan 4, 1977Swift & CompanyEncapsulation process utilizing microorganisms and products produced thereby
US4039653 *Jul 21, 1975Aug 2, 1977Defoney, Brenman, Mayes & BaronBreath deodorants, sustained release
US4105823 *Nov 15, 1976Aug 8, 1978Wiggins Teape LimitedCondensation and crosslinking of prepolymers, acid catalysts, polymeric shells
US4115534 *Jun 20, 1977Sep 19, 1978Minnesota Mining And Manufacturing CompanyComplexing radioactive material with magnetically responsive microparticles
US4138362 *Jan 18, 1977Feb 6, 1979Champion International CorporationFormation of microcapsules by interfacial cross-linking, microcapsules produced, and microcapsular dispersion
US4138505 *Oct 28, 1976Feb 6, 1979Blue Wing CorporationNutrient compositions derived from animal blood solids and process for producing same
US4145184 *Nov 28, 1975Mar 20, 1979The Procter & Gamble CompanyDetergent composition containing encapsulated perfume
US4152272 *Oct 25, 1977May 1, 1979The Procter & Gamble CompanyFabric conditioning composition
US4169804 *Jun 20, 1977Oct 2, 1979Minnesota Mining And Manufacturing CompanyMagnetically responsive composite microparticle
US4184495 *Jun 29, 1978Jan 22, 1980Philip Morris, Inc.Process for incorporating flavorant into cellulosic substrates and products produced thereby
US4217369 *Aug 9, 1976Aug 12, 1980The Pillsbury CompanyMoisture resistant nut-like food composition
US4217370 *Sep 29, 1978Aug 12, 1980Blue Wing CorporationLipid-containing feed supplements and foodstuffs
US4225620 *Aug 26, 1977Sep 30, 1980Blue Wing CorporationAlkali-solubilized protein
US4248899 *Feb 26, 1979Feb 3, 1981The United States Of America As Represented By The Secretary Of AgriculturePressing juice from vegetables, mixing with lipid, emulsification, coagulation
US4273672 *Mar 6, 1974Jun 16, 1981Champion International CorporationMicroencapsulation process
US4331654 *Jun 13, 1980May 25, 1982Eli Lilly And CompanyDrug carrier formulation
US4349530 *Dec 11, 1980Sep 14, 1982The Ohio State UniversityImplants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4357259 *Dec 12, 1977Nov 2, 1982Northwestern UniversityMethod of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
US4388352 *Aug 3, 1981Jun 14, 1983Board Of Regents, University Of WashingtonMicroporous carrier
US4396670 *Mar 24, 1981Aug 2, 1983The Wiggins Teape Group LimitedProcess for the production of microcapsules
US4514461 *Aug 10, 1981Apr 30, 1985Woo Yen KongFragrance impregnated fabric
US4608263 *Sep 11, 1984Aug 26, 1986The Quaker Oats CompanyA heated dispersion of oil, flavoring, and sweetener applied to cerial and cooled
US4660763 *Sep 11, 1985Apr 28, 1987S. C. Johnson & Son, Inc.Vapor-dispensing device
US4666641 *Jun 4, 1985May 19, 1987Universite Paris-Sud (Paris Xi)Crosslinking albumin, adsorption of drug
US4715390 *Nov 19, 1985Dec 29, 1987Philip Morris IncorporatedMatrix entrapment of flavorings for smoking articles
US4729792 *May 22, 1986Mar 8, 1988The Standard Register CompanyDispersion, oils, curing agents, polysalt formation, polyamine, lipophilic, nonpolar
US4798786 *May 6, 1982Jan 17, 1989Stolle Research And Development CorporationLiving cells encapsulated in crosslinked protein
US4898780 *Jan 7, 1988Feb 6, 1990The Standard Register CompanySalt formation of hard, thick walls containing oily soluton
US4956129 *Feb 1, 1988Sep 11, 1990Ici Americas Inc.Microencapsulation process
US5023080 *Jun 17, 1988Jun 11, 1991Basic Bio Systems, Inc.Time release protein
US5055300 *Jun 5, 1989Oct 8, 1991Basic Bio Systems, Inc.Time release protein
US5074902 *Jul 30, 1990Dec 24, 1991Connick Jr William JGranular products containing fungi encapsulated in a wheat gluten matrix for biological control of weeds
US5132117 *Jan 11, 1990Jul 21, 1992Temple UniversityPolymeric Lewis Acids, Lewis Bases
US5143737 *Oct 15, 1990Sep 1, 1992The Regents Of The University Of CaliforniaMethod to produce unsaturated milk fat and meat from ruminant animals
US5332584 *Dec 9, 1991Jul 26, 1994Zeneca Inc.Microcapsules
US5383862 *Dec 14, 1993Jan 24, 1995Telemedysis IncMethod and device for enveloping and disinfecting of sharp instruments
US5418010 *Oct 5, 1990May 23, 1995Griffith Laboratories Worldwide, Inc.Microencapsulation process
US5549903 *Jul 28, 1994Aug 27, 1996Ben Gurion University Of Negev Research & Development AurthorityContains one or more photostable ultraviolet and visible light absorbent compounds
US5578709 *Mar 4, 1994Nov 26, 1996Middlesex Sciences, Inc.Polyvinylpyrrolidone, polyoxyethylene glycol
US5607754 *Jun 1, 1995Mar 4, 1997Kimberly-Clark CorporationPaper web product and method for manufacturing same
US5686113 *Mar 21, 1995Nov 11, 1997Temple University Of The Commonwealth System Of Higher EducationMicrocapsules of predetermined peptide(s) specificity (ies), their preparation and uses
US6090925 *Aug 19, 1996Jul 18, 2000Epic Therapeutics, Inc.Macromolecular microparticles and methods of production and use
US6174514 *Apr 12, 1999Jan 16, 2001Fuisz Technologies Ltd.Breath Freshening chewing gum with encapsulations
US6268053Jan 14, 2000Jul 31, 2001Epic Therapeutics, Inc.Blend of macromolecule and polymer
US6500662Dec 22, 1999Dec 31, 2002Pfizer Inc.Infectious cdna clones of positive polarity rna viruses and the construction of vaccines, in particular, swine vaccines, using such cdna clones
US6531156Jul 12, 1999Mar 11, 2003Temple UniversityAqueous solven encapsulation method, apparatus and microcapsules
US6555110May 4, 1995Apr 29, 2003The Corporation Of Mercer UniversityMicroencapsulated compounds and method of preparing same
US6576264Oct 17, 1996Jun 10, 2003Skyepharma Canada Inc.Insoluble drug delivery
US6610348Nov 14, 2001Aug 26, 2003Fonterra Tech LimitedGelling agents and gels containing them
US6634576Aug 29, 2001Oct 21, 2003Rtp Pharma Inc.At least one composition of media bodies provides fragments of milling media bodies that are retained with the milled solid substrate particles in the form of a synergetic commixture produced in the milling process.
US6682761Apr 20, 2001Jan 27, 2004Rtp Pharma, Inc.Water-insoluble drug particle process
US6890888Jul 2, 2001May 10, 2005Nft Industries, LlcParticles of an absorbent material containing capillaries/voids impregnated with an agriculturally beneficial material selected from the group consisting of fertilizers, insecticides, herbicides and fungicides.
US6911206Feb 16, 2000Jun 28, 2005Pfizer Inc.Fusion proteins comprising carriers that can induce a dual immune response
US6974593Jun 9, 2003Dec 13, 2005Jagotec AgSpraying a compressed fluid comprising a water insoluble active material in solvent, into an aqueous solution comprising a surfactant, forming microparticles; increase the drug bioavailability
US6979456Mar 30, 1999Dec 27, 2005Jagotec Agan emulsion of a taxane; storage-stable, non-aqueous, preconcentrate in a hydrophobic carrier and non-ionic surfactant; improved bioavailability, shelf life
US7041705Mar 26, 2001May 9, 2006Jagotec AgInjectable aqueous dispersions of propofol
US7097849Aug 18, 1999Aug 29, 2006Jagotec AgInjectable aqueous dispersions of propofol
US7132106Sep 11, 2002Nov 7, 2006Pfizer Inc.Plasmid capable of-directly transfecting cell and expressing nidovirales virus; gene therapy; veterinary medicine; genetic vaccines; immunotherapy
US7232680Apr 22, 2002Jun 19, 2007Pfizer Inc.For producing vaccine for protecting a mammal or a bird from infection by a Nidovirales virus
US7255877Mar 31, 1999Aug 14, 2007Jagotec AgFenofibrate microparticles
US7425543Aug 29, 2002Sep 16, 2008The Corporation Of Mercer UniversityMicroencapsulated materials and method of making same
US7618797Oct 25, 2006Nov 17, 2009Pfizer IncInfectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
US7691389Mar 1, 2006Apr 6, 2010Pfizer IncInfectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
US7763238 *Jan 15, 2003Jul 27, 2010Monell Chemical Senses CenterOlfactory adaptation and cross-adapting agents to reduce the perception of body odors
US7939105Nov 19, 1999May 10, 2011Jagotec AgRapidly dispersing solid dry therapeutic dosage
US7939106May 23, 2003May 10, 2011Jagotec AgSurface stabilized fenofibrate particles have a particle size of 10 mu m or less; phospholipid surface modifier; dispersed in a bulking/ releasing matrix
US8147896 *Mar 14, 2007Apr 3, 2012Nestec S.A.Solid product comprising oil-droplets
US8206746Sep 30, 2002Jun 26, 2012Jagotec AgMicroparticles of water-insoluble substances
US8383131Apr 13, 2011Feb 26, 2013Boehringer Ingelheim Vetmedica, Inc.Porcine reproductive and respiratory syndrome isolates and methods of use
US8399187Oct 8, 2009Mar 19, 2013Regents Of The University Of MinnesotaIdentifying virally infected and vaccinated organisms
US8415329May 28, 1999Apr 9, 2013Jagotec AgThermoprotected compositions and process for terminal steam sterilization of microparticle preparations
US8481705Nov 17, 2009Jul 9, 2013Zoetis LlcInfectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
US8492132Oct 28, 2009Jul 23, 2013Zoetis LlcInfectious cDNA clone of north american porcine reproductive and respiratory syndrome (PPRS) virus and uses thereof
US8546124Sep 29, 2005Oct 1, 2013Boehringer Ingelheim Vetmedica GmbhGenerating preferential vector nucleotide sequences, obtaining nucleotide sequences, incubating with preferential exogenous nucleotide sequences, ligating, recovering nucleotide sequences
US8586094May 2, 2003Nov 19, 2013Jagotec AgCoated tablets
US8609827Nov 10, 2009Dec 17, 2013Zoetis LlcInfectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
US8668930Mar 29, 2006Mar 11, 2014Mycone Dental Supply Co., Ltd.Durable film coating compositions having sustained slow-release capability, and methods of use therefor
US8684739Mar 14, 2003Apr 1, 2014Mycone Dental Supply Co., Inc.Durable film coating compositions having sustained slow-release capability, and methods of use therefor
US8703202Jul 24, 2006Apr 22, 2014Jagotec AgCoated tablets
US8741309Jul 24, 2006Jun 3, 2014The United States Of America As Represented By The Secretary Of AgriculturePorcine reproductive and respiratory syndrome vaccine based on isolate JA-142
US8747859Feb 20, 2009Jun 10, 2014The United States Of America, As Represented By The Secretary Of AgriculturePorcine reproductive and respiratory syndrome vaccine based on isolate JA-142
US8765142Feb 14, 2012Jul 1, 2014Boehringer Ingelheim Vetmedica GmbhEuropean PRRSV strain
US8790656Jun 8, 2006Jul 29, 2014Boehringer Ingelheim Vetmedica GmbhPRRSV vaccines
US20120034337 *Dec 29, 2009Feb 9, 2012Friesland Brands B.V.Protein particles and their use in food
USB498208 *Aug 16, 1974Apr 13, 1976 Title not available
USRE29066 *Mar 15, 1974Dec 7, 1976Minnesota Mining And Manufacturing CompanyBiodegradable radioactive particles
USRE32713 *Mar 3, 1986Jul 12, 1988 Capsule impregnated fabric
EP0093668A1 *Apr 29, 1983Nov 9, 1983Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)Microcapsules having a wall of reticulately bound milk proteins, and method for their preparation
EP0349428A1 *Jun 28, 1989Jan 3, 1990Centre National De La Recherche Scientifique (Cnrs)Process for preparing colloidal dispersive protein systems in the shape of nanoparticles
EP1627919A1Nov 25, 1999Feb 22, 2006Pfizer Products Inc.An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
WO1979000111A1 *Aug 24, 1978Mar 8, 1979Blue Wing CorpImproved lipid-containing feed supplements and foodstuffs
WO1982001994A1 *Dec 9, 1981Jun 24, 1982Univ OhioImplants,microbeads,microcapsules,and method for their preparation
WO1984000304A1 *Jul 8, 1982Feb 2, 1984Harman MitchellInjectible sustained release dosage cylinders
WO1985000011A1 *Jun 14, 1984Jan 3, 1985Univ MiamiMicrodroplets of water-insoluble drugs
WO1991005482A1 *Oct 15, 1990May 2, 1991Univ CaliforniaMethod to produce unsaturated milk fat and meat from ruminant animals
WO2010044889A2Oct 16, 2009Apr 22, 2010Pfizer Inc.Torque teno virus (ttv) isolates and compositions
WO2012168818A1May 24, 2012Dec 13, 2012Ah Usa 42 LlcInfectious clones of torque teno virus
Classifications
U.S. Classification424/491, 131/337, 426/98, 264/4.1, 428/402.2, 264/4, 512/4, 162/158, 264/4.7
International ClassificationA61K9/50, B01J13/08, B01J13/06
Cooperative ClassificationB01J13/08, A61K9/50
European ClassificationA61K9/50, B01J13/08